JPS59227817A - 持続性経口用ブレデニン製剤 - Google Patents

持続性経口用ブレデニン製剤

Info

Publication number
JPS59227817A
JPS59227817A JP10217583A JP10217583A JPS59227817A JP S59227817 A JPS59227817 A JP S59227817A JP 10217583 A JP10217583 A JP 10217583A JP 10217583 A JP10217583 A JP 10217583A JP S59227817 A JPS59227817 A JP S59227817A
Authority
JP
Japan
Prior art keywords
bredenine
component
predenine
acrylic acid
vivo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10217583A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0530810B2 (enrdf_load_stackoverflow
Inventor
Takafumi Matsumura
松村　隆文
Mutsuhiro Mori
森　睦博
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Jozo KK
Original Assignee
Toyo Jozo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Jozo KK filed Critical Toyo Jozo KK
Priority to JP10217583A priority Critical patent/JPS59227817A/ja
Publication of JPS59227817A publication Critical patent/JPS59227817A/ja
Publication of JPH0530810B2 publication Critical patent/JPH0530810B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP10217583A 1983-06-07 1983-06-07 持続性経口用ブレデニン製剤 Granted JPS59227817A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10217583A JPS59227817A (ja) 1983-06-07 1983-06-07 持続性経口用ブレデニン製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10217583A JPS59227817A (ja) 1983-06-07 1983-06-07 持続性経口用ブレデニン製剤

Publications (2)

Publication Number Publication Date
JPS59227817A true JPS59227817A (ja) 1984-12-21
JPH0530810B2 JPH0530810B2 (enrdf_load_stackoverflow) 1993-05-11

Family

ID=14320345

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10217583A Granted JPS59227817A (ja) 1983-06-07 1983-06-07 持続性経口用ブレデニン製剤

Country Status (1)

Country Link
JP (1) JPS59227817A (enrdf_load_stackoverflow)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62246512A (ja) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd 反復作用製剤
JPS63255230A (ja) * 1987-03-27 1988-10-21 ザ　ウエルカム　フアウンデーシヨン　リミテツド 徐放性製剤
JPH01287020A (ja) * 1988-05-13 1989-11-17 Shin Etsu Chem Co Ltd ワックス被覆徐放性製剤
JPH02282323A (ja) * 1989-04-21 1990-11-19 Shin Etsu Chem Co Ltd 徐放性錠剤の製造方法
JPH0482825A (ja) * 1990-07-25 1992-03-16 Ss Pharmaceut Co Ltd 徐放性錠剤
EP0661054A4 (en) * 1991-08-06 1994-05-17 Asahi Chemical Ind COMPOSITION FOR TREATING PROLIFERATIVE DERMAL CONDITIONS.
JPH08512021A (ja) * 1993-04-29 1996-12-17 バークメイヤー ユー．エス．エー． 安定性、摂取可能及び吸収性のｎａｄｈ及びｎａｄｐｈ治療組成物
US9238029B2 (en) 2004-06-16 2016-01-19 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
WO2017115745A1 (ja) * 2015-12-28 2017-07-06 エスエス製薬株式会社 圧縮成型製剤

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54129115A (en) * 1978-03-31 1979-10-06 Yasuyo Miyauchi Long acting amoxycilin preparation
JPS5512410A (en) * 1978-07-12 1980-01-29 Toshiba Corp Device for acoustic holography
JPS56103110A (en) * 1980-01-11 1981-08-18 Boots Co Ltd Sustained release medicinal composition
JPS57156418A (en) * 1981-03-19 1982-09-27 Sumitomo Chem Co Ltd Carcinostatic
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
JPS5883613A (ja) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk 硝酸イソソルビト−ル製剤

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54129115A (en) * 1978-03-31 1979-10-06 Yasuyo Miyauchi Long acting amoxycilin preparation
JPS5512410A (en) * 1978-07-12 1980-01-29 Toshiba Corp Device for acoustic holography
JPS56103110A (en) * 1980-01-11 1981-08-18 Boots Co Ltd Sustained release medicinal composition
JPS57156418A (en) * 1981-03-19 1982-09-27 Sumitomo Chem Co Ltd Carcinostatic
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
JPS5883613A (ja) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk 硝酸イソソルビト−ル製剤

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62246512A (ja) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd 反復作用製剤
JPS63255230A (ja) * 1987-03-27 1988-10-21 ザ　ウエルカム　フアウンデーシヨン　リミテツド 徐放性製剤
JPH01287020A (ja) * 1988-05-13 1989-11-17 Shin Etsu Chem Co Ltd ワックス被覆徐放性製剤
JPH02282323A (ja) * 1989-04-21 1990-11-19 Shin Etsu Chem Co Ltd 徐放性錠剤の製造方法
JPH0482825A (ja) * 1990-07-25 1992-03-16 Ss Pharmaceut Co Ltd 徐放性錠剤
EP0661054A4 (en) * 1991-08-06 1994-05-17 Asahi Chemical Ind COMPOSITION FOR TREATING PROLIFERATIVE DERMAL CONDITIONS.
JPH08512021A (ja) * 1993-04-29 1996-12-17 バークメイヤー ユー．エス．エー． 安定性、摂取可能及び吸収性のｎａｄｈ及びｎａｄｐｈ治療組成物
US9238029B2 (en) 2004-06-16 2016-01-19 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
US9889152B2 (en) 2004-06-16 2018-02-13 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
WO2017115745A1 (ja) * 2015-12-28 2017-07-06 エスエス製薬株式会社 圧縮成型製剤
JPWO2017115745A1 (ja) * 2015-12-28 2018-10-18 エスエス製薬株式会社 圧縮成型製剤

Also Published As

Publication number Publication date
JPH0530810B2 (enrdf_load_stackoverflow) 1993-05-11

Similar Documents

Publication Publication Date Title
EP0605174B1 (en) Delayed, Sustained-release pharmaceutical preparation
US4968505A (en) Long-acting diclofenac sodium preparation
US5508044A (en) Diltiazem pharmaceutical spheroid formulation
ES2606463T3 (es) Combinación de formas de dosificación de levodopa/carbidopa de liberación inmediata y liberación controlada
AU571312B2 (en) Diffusion coated multiple-units dosage form
US6491950B1 (en) Controlled release pharmaceutical composition
EP1010423A2 (en) Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
JPH0122245B2 (enrdf_load_stackoverflow)
JP4572300B2 (ja) ピモベンダン経口投与製剤
US5651983A (en) Bisacodyl dosage form for colonic delivery
US7138143B1 (en) Coated preparation soluble in the lower digestive tract
JPS6327424A (ja) 徐放性製剤およびその製造法
US6558700B1 (en) Multiple-unit sustained release tablets
JP4540092B2 (ja) 酸に不安定な生理活性化合物を含有する製剤組成物及びその製法
JPS59227817A (ja) 持続性経口用ブレデニン製剤
JPS6144811A (ja) 徐放性ジクロフエナクナトリウム製剤
JP2007522258A (ja) 塩酸タムスロシンの経口投与用組成物及びその徐放性顆粒製剤
KR20000036039A (ko) 방출 조절된 [Ｒ-(Ｚ)]-α-(메톡시이미노)-α-(1-아자비시클
JPH0776517A (ja) 医薬用組成物
US20060039997A1 (en) Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
US5726201A (en) Gemfibrozil containing pharmaceutical compositions
JPS58172311A (ja) 持続性製剤及びその製法
JPS63267720A (ja) エモルフアゾンの徐放性製剤
JP2010511023A (ja) メマンチンの製剤組成物
JPH04338323A (ja) 放出制御製剤およびその製造法